| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |